Page 2 - ஆயுட்காலம் ஓனேதொச் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆயுட்காலம் ஓனேதொச். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆயுட்காலம் ஓனேதொச் Today - Breaking & Trending Today

LifeCell announces special offers on its newborn screening package

LifeCell announces special offers on its newborn screening package
LifeCell announces special offers on its newborn screening package
19 February 2021 | News
Newborn screening is a programme that identifies babies at risk of having rare, but serious medical conditions that can affect normal development. BabyShield Newborn Screening combines biochemical testing of 100+ metabolic & genetic conditions with confirmatory genetic testing for screen-positive results. It aims to achieve the early identification of conditions
Source: www.lifecell.in
Early detection and intervention are key for treating childhood on-set disorders. In an effort to create awareness about the same, LifeCell, India’s largest stem cell bank announced special offers on its newborn screening package. Aligned with Rare Disorder Awareness month, the offer encourages parents to enrol with LifeCell and have their newborn babies screened for life-threatening ailments with additional upgr ....

Rare Disorder Awareness , Shield Newborn Screening , Stem Cell , Newborn Screening , Rare Disorder Awareness Month , Newborn Babies , ரேர் கோளாறு விழிப்புணர்வு , கவசம் புதிதாகப் பிறந்தவர் திரையிடல் , தண்டு செல் , புதிதாகப் பிறந்தவர் திரையிடல் , ரேர் கோளாறு விழிப்புணர்வு மாதம் , புதிதாகப் பிறந்தவர் குழந்தைகள் ,

Relay Medical Corp.: Relay Medical Reports Glow LifeTech Secures Exclusive North American Rights to ArtemiC Following Successful COVID-19 Phase II Clinical Trial

Relay Medical Corp.: Relay Medical Reports Glow LifeTech Secures Exclusive North American Rights to ArtemiC Following Successful COVID-19 Phase II Clinical Trial
Relay or the
Company ), a technology developer and innovator, and Glow LifeTech Ltd. (
Glow ), a private company in which Relay holds a significant equity interest, are pleased to report that Glow has executed an agreement with Swiss Pharmacan AG ( the agreement ) for exclusive North American and Carribean sales and distribution rights for ArtemiC , a natural health product based on Glow s MyCell Technology ( MyCell ) which recently reported successful results from a COVID-19 Phase II clinical trial (see Relay s release dated Jan 14, 2021). ....

United States , W Clark Kent , Rob Carducci , Yoav Raiter , Bernhard Langer , Relay Medical Corp , Glow Mycell Technology , Glow Lifetech Ltd , Pharmaceuticals Ltd , Newsfile Corp , Mycell Technology , Micelle Technology , Swiss Pharmacan Ag Micelle Technology , Placebo Group , Glow Lifetech , Swiss Pharmacan , North American , Chief Commercial Officer , Relay Medical , Medi Cal , Co Vid , ஒன்றுபட்டது மாநிலங்களில் , டப்ல்யூ கிளார்க் கேண்ட் , கொள்ளை கார்டுக்ஸி , பெர்ன்ஹார்ட் லாங்கர் , ரிலே மருத்துவ கார்ப் ,

Relay Medical Corp.: Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology

(2)
Glow LifeTech has the exclusive rights for MyCell Technology in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC, a COVID-19 Treatment Candidate with successful Phase II Clinical Results
The formulation statistically significantly improved the clinical recovery of COVID-19 patients in the treatment group in comparison with placebo and 100% of the patients in the treatment group fully recovered within 15 days
Positive results from a phase II double blind randomized controlled clinical trial show the MyCell Technology ArtemiC formulation, successfully met the primary and secondary endpoints for safety and efficacy
1
ArtemiC is a natural anti-inflammatory formulation by Glow partner Swiss PharmaCan and MGC Pharma, intended to suppress cytokine storm and clinical deterioration prevention to support the recovery of COVID-19 patients ....

United States , W Clark Kent , Clark Kent , Bernhard Langer , Relay Medical Corp , Glow Mycell Technology , Glow Lifetech Ltd , Pharmaceuticals Ltd , Mycell Technology Artemi , Swiss Pharmacan Ag Micelle Technology , Mycell Technology , Micelle Technology , Placebo Group , Canadian Securities Exchange , Ateba Resources Inc , Glow Lifetech , Mycell Technology Artemic , Swiss Pharmacan , North American , Boswellia Serrata , Chief Executive Officer , North America , With Glow , Managing Director , Ateba Resources , Medi Cal ,